Difference between revisions of "Iron sucrose (Venofer)"
Jump to navigation
Jump to search
m (Text replacement - "[[File:" to "[[:File:") |
m |
||
| Line 12: | Line 12: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | *11 | + | *2000-11-06: Approved for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD). |
==Also known as== | ==Also known as== | ||
Revision as of 12:54, 9 May 2023
General information
Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.[1][2][3]
Route: IV
Extravasation: no information
- 1 mL of Venofer provides 20 mg of elemental iron
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Brief patient counseling information can be found in the Iron sucrose (Venofer) package insert[1]
- Iron sucrose (Venofer) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 2000-11-06: Approved for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
Also known as
- Brand name: Venofer